PRESS INFORMATION
CHI's Molecular Medicine Tri-Conference invites accredited media working for scientific news organizations to register for a complimentary press pass. This event will provide members of the media access to:
  • Over 250 presentations covering 11 tracks (February 3-5) 
  • 9 Science and Business Short Courses and Tutorials (February 2) 
  • Keynote Presenters
  • 75+ exhibitors in the Exhibit Hall 
  • 70+ Scientific Posters 
  • Vendor Theatre Presentations 
  • Interactive Roundtable Discussions 
  • Use of CHI’s Intro-Net 
  • .....and more! 

Press passes are limited, and are granted only to working journalists who intend to cover the event. To qualify for press credentials, you must be affiliated with an internationally, nationally or regionally recognized media outlet, and hold an editorial title and or hold a position as an industry analyst. 

Personnel that are in sales, advertising, marketing, account management, or other non-editorial professions will not be granted a press or analyst pass. (CHI reserves the right to request documentation regarding credentials.)

Please email a copy of your completed article, along with the anticipated publish date to Tracey Fielding at tfielding@healthtech.com

Media and Press Contact:
If you have any questions regarding press access or wish to become a media partner for the event contact:
Tracey Fielding
Phone: 781-972-5429
Email: tfielding@healthtech.com

Please select which programs you will be attending:

All Fields Required
Pre-Conference Short Courses and Tutorial (February 24):
  MORNING SHORT COURSES   AFTERNOON SHORT COURSES
(SC1) Applying Next Generation Sequencing Technologies To Research (SC7) Best Practices In Translational & Personalized Medicine
(SC2) One Case Study In Breast Cancer-Three Perspectives (SC8) Strategies for Molecular Diagnostic Companies
(SC3) Mighty Mitochondria: Why, How and When to Assess their Function (SC9) Fragment - Inspired Medicinal Chemistry
(SC4) Addressing Safety Concerns For Biological Drugs (SC10) Transporter-Mediated Drug-Drug Interaction Potential
(SC5) Targeting Cancer Stem Cells With Biologics (SC11) Basic Immersion in Cutting Edge Science and Technology
  (SC6) Blood-Brain Barrier    
       
Program Selection: Main Conference Feb 3-5 (REQUIRED)
Please indicate the ONE program you are most likely to attend.
Diagnostics Channel Chemistry Channel

Molecular Diagnostics
Personalized Diagnostics
Cancer Molecular Markers

 Mastering Medicinal Chemistry
Informatics Channel Biologics Channel
Adopting R&D Informatics Systems
Cancer Profiling and Pathways		 Stem Cells
RNA Interference
Cancer Biologics
Delivery of Biologics
Cancer Channel Executive Channel
Cancer Biologics
Cancer Molecular Markers
Cancer Profiling and Pathways		 Translational Medicine
 Mr.     Ms.     Mrs.     Dr.     Prof.
  First:  
  Last:  
  Title:  
  Div/Dept.:  
  Company:  
Publisher:  
The journal you will be representing:  
When is the anticipated article publish date?  
Publication Editor:  
Address:  
City:  
State:    Zip:
Country:  
  Email:  
Website URL:  

Phone and fax numbers are required to process form
Phone: Fax:

How did you hear about this event:

Conference brochure Colleague  Calendar listing CHI email Print ad On another web site Newsgroup posting 
Other

Please email a copy of your completed article, along with the anticipated publish date to Tracey Fielding at tfielding@healthtech.com
  
 



 

Premier Sponsors



Corporate Sponsors



















Corporate Support Sponsors



Media Partners


Co-Sponsors

 

Cambridge Healthtech Institute  |  250 First Avenue  |  Suite 300   |   Needham,  MA  02494
Phone: 781-972-5400  |   Fax: 781-972-5425
chi@healthtech.com

Your  Life Science Network